3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Renal Failure: new trials by email Literature Review of Renal Failure trials Research Report on Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure Bortezomib, Daratumumab, Dexamethasone - Plasma Cell Myeloma, Renal Failure | Phase 2 | Terminated | Emory University | 17 | 2020-05-07 | 2024-07-01 |
| Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC Natrecor (nesiritide)+Standard Care+dobutamine or milrinone, Placebo+Standard Care+dobutamine or milrinone - Congestive Heart Failure, Cardiac Transplantation | Phase 2 | Terminated | Scios, Inc. | 16 | 2006-09-01 | 2014-12-08 |
| COOL RCN: Cooling to Prevent Radiocontrast Nephropathy Reprieve Endovascular Temperature Therapy System - Renal Failure, Kidney Failure | Phase 2 / Phase 3 | Terminated | Radiant Medical | 400 | 2006-03-01 | 2008-08-05 |
Renal Insufficiency (3) · Heart Failure (1) · Multiple Myeloma (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Cardiovascular Diseases (2) · Blood Protein Disorders (1) · Heart Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Bortezomib (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Lenalidomide (1) · Milrinone (1) · Natriuretic Peptide, Brain (1) · Thalidomide (1) · auricularum (1) · daratumumab (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1)
Emory University (1) · Radiant Medical (1) · Scios, Inc. (1)
United States (3)
Gregg Stone, MD (1) · R. Donald Harvey, PharmD (1)
P30CA138292 (1)